NO130943B - - Google Patents
Download PDFInfo
- Publication number
- NO130943B NO130943B NO43271A NO43271A NO130943B NO 130943 B NO130943 B NO 130943B NO 43271 A NO43271 A NO 43271A NO 43271 A NO43271 A NO 43271A NO 130943 B NO130943 B NO 130943B
- Authority
- NO
- Norway
- Prior art keywords
- setting device
- pin
- piece
- sleeve
- damping piston
- Prior art date
Links
- 239000000463 material Substances 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims 7
- 238000004873 anchoring Methods 0.000 claims 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 239000007789 gas Substances 0.000 claims 2
- 239000003380 propellant Substances 0.000 claims 2
- 238000004140 cleaning Methods 0.000 claims 1
- 238000002485 combustion reaction Methods 0.000 claims 1
- 239000004567 concrete Substances 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 239000002360 explosive Substances 0.000 claims 1
- 238000010304 firing Methods 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical class OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 17
- -1 amine salts Chemical class 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 10
- 229960001214 clofibrate Drugs 0.000 description 9
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000004985 diamines Chemical class 0.000 description 3
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical class NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- MDLKWDQMIZRIBY-UHFFFAOYSA-N 1-(dimethylamino)ethanol Chemical class CC(O)N(C)C MDLKWDQMIZRIBY-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000005263 alkylenediamine group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- HUIKLQYJFNQHCJ-UHFFFAOYSA-N butyl 2-(4-chlorophenoxy)-2-methylpropanoate Chemical compound CCCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 HUIKLQYJFNQHCJ-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical class CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- UXIVINXAZVEIMC-UHFFFAOYSA-N methyl 2-(4-chlorophenoxy)-2-methylpropanoate Chemical compound COC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 UXIVINXAZVEIMC-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- OWWSWMUOQSRTBU-UHFFFAOYSA-N propyl 2-(4-chlorophenoxy)-2-methylpropanoate Chemical compound CCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 OWWSWMUOQSRTBU-UHFFFAOYSA-N 0.000 description 1
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical class NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US941770A | 1970-02-06 | 1970-02-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO130943B true NO130943B (OSRAM) | 1974-12-02 |
| NO130943C NO130943C (OSRAM) | 1975-03-12 |
Family
ID=21737522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO43271A NO130943C (OSRAM) | 1970-02-06 | 1971-02-05 |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5118484B1 (OSRAM) |
| CA (1) | CA957373A (OSRAM) |
| CH (1) | CH540214A (OSRAM) |
| DE (1) | DE2105418C3 (OSRAM) |
| FR (1) | FR2081494B1 (OSRAM) |
| GB (1) | GB1336632A (OSRAM) |
| NO (1) | NO130943C (OSRAM) |
| SE (1) | SE375756B (OSRAM) |
-
1971
- 1971-02-02 CH CH151271A patent/CH540214A/fr not_active IP Right Cessation
- 1971-02-05 SE SE144671A patent/SE375756B/xx unknown
- 1971-02-05 FR FR7103963A patent/FR2081494B1/fr not_active Expired
- 1971-02-05 DE DE19712105418 patent/DE2105418C3/de not_active Expired
- 1971-02-05 JP JP46004680A patent/JPS5118484B1/ja active Pending
- 1971-02-05 NO NO43271A patent/NO130943C/no unknown
- 1971-02-08 CA CA104,687A patent/CA957373A/en not_active Expired
- 1971-04-19 GB GB2119271A patent/GB1336632A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1336632A (en) | 1973-11-07 |
| FR2081494A1 (OSRAM) | 1971-12-03 |
| DE2105418C3 (de) | 1975-11-27 |
| CA957373A (en) | 1974-11-05 |
| CH540214A (fr) | 1973-08-15 |
| JPS5118484B1 (OSRAM) | 1976-06-10 |
| DE2105418A1 (de) | 1971-08-12 |
| FR2081494B1 (OSRAM) | 1975-04-18 |
| NO130943C (OSRAM) | 1975-03-12 |
| DE2105418B2 (de) | 1975-04-24 |
| SE375756B (OSRAM) | 1975-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2263328C (en) | Use of .gamma.-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism | |
| AU621667B2 (en) | Sulphonamido-phenylalkanoic acid derivatives having thromboxane A2 antagonist activity | |
| EP0112130B1 (en) | Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids, their preparation and use | |
| US5665774A (en) | Immunosuppressive compounds | |
| EP1438298B1 (en) | Piperazine derivatives with ccr1 receptor antagonist activity | |
| BR112014010576B1 (pt) | Compostos inibidores de neprilisina (nep), seus usos, processo de preparação dos compostos e composição farmacêutica compreendendo os compostos | |
| RU2000129672A (ru) | Производные хинолина | |
| CA2035544A1 (en) | Heterocyclic derivatives | |
| JP2023533203A (ja) | セレブロン結合化合物、その組成物及びそれによる治療方法 | |
| CS208798B2 (en) | Method of making the new derivatives of the n-substituted aziridin-2-carboxyl acid | |
| NO130943B (OSRAM) | ||
| KR950703557A (ko) | 약제로서 사용되는 헤테로아릴 화합물(Heteroaryl Compounds Used as Pharmaceuticals) | |
| RU2756223C2 (ru) | Кристаллическая (2s,4r)-5-(5'-хлор-2'-фтор-[1,1'-бифенил]-4-ил)-2-(этоксиметил)-4-(3-гидроксиизоксазол-5-карбоксамидо)-2-метилпентановая кислота и ее применения | |
| AU598584B2 (en) | Benzhydryloxyethylpiperidine derivatives, process for their preparation and pharmaceutical compositions in which they are present | |
| EP0079810B1 (fr) | Nouveaux dérivés de la phényl-4 quinazoline actifs sur le système nerveux central | |
| US4060638A (en) | Anthranilic acid amides | |
| RU2067579C1 (ru) | 3-(2'-нафтоилметилен)-пиперазинон-2 и 1-n-фенил-3-фенацилиденпиперазинон-2, проявляющие противовоспалительную активность | |
| AU672984B2 (en) | Novel oxazolidines | |
| US3420847A (en) | Pyrrolyl-lower-alkyl-amidoximes | |
| US2836599A (en) | Nu-(carboxyalkyl) dinitro lactams | |
| AU661906B2 (en) | 5-amino-2-phenoxysulfonanilide compound | |
| US3892860A (en) | 4,6-Diaryl-pyrimidin-2(1H)-ones as sleep-inducers | |
| DE69211773T2 (de) | Amidderivate von 1-Amino-Octahydropyrido[2,1-c][1,4]oxazin, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
| JP2008543941A (ja) | アンサマイシン製剤およびその使用方法 | |
| EP1453793A2 (en) | New pharmaceutical compounds |